U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS
This repository is under review for potential modification in compliance with Administration directives.

Details

Stereochemistry ABSOLUTE
Molecular Formula C14H18N2O
Molecular Weight 230.3055
Optical Activity UNSPECIFIED
Defined Stereocenters 1 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of LUCIGENOL

SMILES

CN1CCC[C@@H]1CC2=CNC3=C2C(O)=CC=C3

InChI

InChIKey=XYRKPZYRLSWABB-LLVKDONJSA-N
InChI=1S/C14H18N2O/c1-16-7-3-4-11(16)8-10-9-15-12-5-2-6-13(17)14(10)12/h2,5-6,9,11,15,17H,3-4,7-8H2,1H3/t11-/m1/s1

HIDE SMILES / InChI

Molecular Formula C14H18N2O
Molecular Weight 230.3055
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 1 / 1
E/Z Centers 0
Optical Activity UNSPECIFIED

Approval Year

Substance Class Chemical
Created
by admin
on Mon Mar 31 23:13:41 GMT 2025
Edited
by admin
on Mon Mar 31 23:13:41 GMT 2025
Record UNII
46OU9HLZ35
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
LUCIGENOL
Common Name English
4-HO-MPMI
Preferred Name English
4-HYDROXY-N-METHYL-(.ALPHA.,N-TRIMETHYLENE)TRYPTAMINE
Common Name English
1H-INDOL-4-OL, 3-(((2R)-1-METHYL-2-PYRROLIDINYL)METHYL)-
Systematic Name English
Classification Tree Code System Code
WIKIPEDIA Designer-drugs-4-HO-MPMI
Created by admin on Mon Mar 31 23:13:41 GMT 2025 , Edited by admin on Mon Mar 31 23:13:41 GMT 2025
Code System Code Type Description
CAS
250672-65-2
Created by admin on Mon Mar 31 23:13:41 GMT 2025 , Edited by admin on Mon Mar 31 23:13:41 GMT 2025
PRIMARY
PUBCHEM
10466404
Created by admin on Mon Mar 31 23:13:41 GMT 2025 , Edited by admin on Mon Mar 31 23:13:41 GMT 2025
PRIMARY
EPA CompTox
DTXSID80440389
Created by admin on Mon Mar 31 23:13:41 GMT 2025 , Edited by admin on Mon Mar 31 23:13:41 GMT 2025
PRIMARY
WIKIPEDIA
4-HO-MPMI
Created by admin on Mon Mar 31 23:13:41 GMT 2025 , Edited by admin on Mon Mar 31 23:13:41 GMT 2025
PRIMARY 4-HO-MPMI (also known as 4-Hydroxy-N-methyl-(α,N-trimethylene)tryptamine or lucigenol) is a tryptamine derivative that is a psychedelic drug. It was developed by the team led by David Nichols from Purdue University in the late 1990s. This compound produces hallucinogen-appropriate responding in animal tests with a similar potency to the amphetamine-derived psychedelic DOI, and has two enantiomers, with only the (R)-enantiomer being active.
FDA UNII
46OU9HLZ35
Created by admin on Mon Mar 31 23:13:41 GMT 2025 , Edited by admin on Mon Mar 31 23:13:41 GMT 2025
PRIMARY
Related Record Type Details
TARGET -> AGONIST
Related Record Type Details
ACTIVE MOIETY